PillRx only · Injection, Solution · Subcutaneous
Lebrikizumab-Lbkz
Brands: Ebglyss · Lebrikizumab
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers1 labelers
Packages4
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1785.132
Latest avg · Jun 17, 2026
+4%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Eli Lilly and Company | unknown | 4 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.